Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.33
0.02 (1.53%)
At close: Aug 15, 2025, 1:15 PM
13F Institute Ownership
Total Institutes of 29 in Citius Pharmaceuticals reduced their positions with a decrease of 4 investors compared to the previous quarter. An additional 26.24K shares, as total invested capital declined by $1.48M with ownership percentage increasing from 5.26% to 5.48%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.522
0.52
Call Flow 18,780
66%
Put Flow 9,800
34%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 2.22% | 257.63K | +0.00% | 383.87K | < 0.01% | May 09, 2025 |
| Geode Capital Management, LLC | 0.77% | 89.28K | +16.69% | 133.05K | < 0.01% | May 13, 2025 |
| Blackrock, Inc. | 0.62% | 72.23K | +0.00% | 107.62K | < 0.01% | May 02, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.